Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
This article contrasts Zero Based Budgeting with Cash Flow Budgeting, outlining focus areas, strengths, and situations where one excels.
23,456 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Adobe faces a pivotal shift as its own AI tool accelerates cannibalization of the stock library, forcing a rethinking...
OpenAI just took first steps toward an IPO, signaling a new wave of AI market access. This guide explains what it mea...
FuelCell Energy leads a morning surge in hydrogen names, delivering outsized gains while peers lag. Analysts point to...
A Sioux Falls crypto investor faces 29 federal counts in a scheme prosecutors say used eight entities and new investo...
IBM's shares sank as Anthropic's Claude Code intensifies AI competition, pushing ibm’s stock heads worst for a month ...
Veeva Systems prepares to unveil Q4 FY2026 after the bell, with investors weighing durable renewals against software ...
The VIX surges about 10% as Brent breaches the $100 mark, signaling rising fear among traders and a shift toward risk...
Redwire stock jumped on intraday momentum before giving back gains. This article unpacks the forces behind the pop-a...
A small-cap memory-interface provider, Lumina IP, reports gross margins near 80% in Q1 2026 as AI accelerators push d...
In a week-long burst of closings, six starter units priced at $90k-$140k sold, five via seller financing. The episode...
Beaten-down SaaS shares stage a comeback as AI fears fade. This report explains why the AI panic didn’t kill saas aft...